Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...

Flow cytometry is a powerful, emerging technology that can help medical professionals better understand disease, according to Dr. Bill Hanlon, chief scientific officer of Labcorp Drug Development.

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...

Shares of medical technology company Becton, Dickinson And Company (NYSE:BDX) are trading higher after the company said it will acquire Edwards Lifesciences Corp’s (NYSE:EW) Critical Care product ...

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson ...

Becton, Dickinson and Company BDX, popularly known as BD, launched a new advanced hemodynamic monitoring platform, HemoSphere Alta, yesterday. The platform is equipped with predictive, artificial ...

BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...

The Parata Systems team will work with BD’s medication management solutions business, according to a July 18 news release. The company plans to focus on issues including clinician shortages, wage ...